13F-HR filed by TANG CAPITAL MANAGEMENT LLC
TANG CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:15:17 UTC, with 45 holding rows worth $2,173,767,967.
- Accession
- 0001214659-26-014410
- Filer
- CIK 1232621
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 45 entries on the cover page, a total value of $2,173,767,967 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,173,767,967 with VALUE read as dollars as filed, 13F file number 028-14822. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerTANG KEVIN028-14818
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 13,044,106 | $211,249,297 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 1,500,000 | $172,845,000 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 2,259,889 | $168,610,318 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 1,892,200 | $168,462,566 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,917,666 | $150,747,724 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 3,985,991 | $118,184,633 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 1,464,594 | $116,464,515 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 1,236,027 | $105,655,588 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 1,500,000 | $97,170,000 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 2,884,149 | $87,360,873 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 1,474,262 | $74,096,408 | dollars as filed | |
| SPY | 78462F103 | SHS | 95,000 | $72,449,850 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 5,200,000 | $64,688,000 | dollars as filed | |
| PRECIGEN INC | 74017N105 | COM | 6,417,500 | $54,933,800 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 707,500 | $51,399,875 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 470,000 | $46,201,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,792,626 | $36,910,169 | dollars as filed | |
| NUVECTIS PHARMA INC | 67080T108 | COMMON STOCK | 1,577,968 | $33,326,684 | dollars as filed | |
| NANO DIMENSION LTD | 63008G203 | SPONSORD ADS NEW | 20,926,847 | $32,855,150 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 9,047,134 | $30,941,198 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 7,080,945 | $26,199,497 | dollars as filed | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 4,814,700 | $25,084,587 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 264,692 | $23,306,131 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 17,990,782 | $18,710,413 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 3,299,557 | $18,477,519 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 450,000 | $17,289,000 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 1,160,000 | $16,924,400 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 500,000 | $16,300,000 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 500,000 | $16,145,000 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 700,000 | $13,923,000 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 7,285,085 | $12,166,092 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 100,000 | $11,414,000 | dollars as filed | |
| GOSSAMER BIO INC | 38341PAA0 | NOTE 5.000% 6/0 | 17,841,000 | $11,160,081 | dollars as filed | principal |
| JOURNEY MED CORP | 48115J109 | COM | 1,610,000 | $11,012,400 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 50,000 | $9,628,500 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 300,000 | $7,800,000 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 2,840,635 | $7,129,994 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 6,141,261 | $6,632,562 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 8,971,427 | $2,812,542 | dollars as filed | |
| Wave Life Sciences Inc. | 94352A104 | COM | 600,000 | $2,220,000 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 666,022 | $1,904,823 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 451,114 | $1,732,278 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 125,000 | $657,500 | dollars as filed | |
| SKYE BIOSCIENCE INC COM | 83086J309 | Stock | 200,000 | $322,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 100,000 | $263,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-26-014410 | this filing | 2026-11-16 |